ALL CORRECT ANSWERS
What is position effect variegation? - Answer-Altered gene expression occuring when a
gene is transferred from euchromatic region to heterochromatic region (or vice versa).
Explain the role of HATs, HDACs, and SWI/SNF in chromatin remodelling. - Answer-
HATs: acetylate histone lysine residues resulting in loosening of DNA-nucleosome
interaction - more open chromatin
HDACs: remove acetyl groups resulting in chromatin compaction.
SWI/SNF: shifts nucleosomes along DNA to clear promoter regions for TF binding.
Explain the phenomena of DNA methylation and gene imprinting. - Answer-DNA
methyltransferases attach methyl groups to cytosine residues in CpG dinucleotides to
create C5-methylcytosine. Methylation of gene promoters recruits chromatin modifying
proteins resulting in chromatin compaction and inhibition of gene expression.
Imprinted genes: methylation pattern of a gene is determined by its parental origin.
Why is the alternate splicing of mRNA significant? - Answer-mRNA transcripts can be
processed to include or exclude different exons such that the various
mature mRNAs can be translated into proteins with different functions.
Explain the cytoplasmic control of mRNA stability. - Answer-PABP1/eIF-4E mediated
circularization prevents mRNA decay. Deadenylation allows binding of deadenylating
enzyme to destabilize sequence AUUUA in the 3'UTR of short-lived mRNAs.
Describe the process of miRNA biogenesis. - Answer-miRNAS synthesized as pri-
miRNA with ds hairpin structure. Drosha removes ends of hairpin producing pre-miRNA
that is exported to cytoplasm. Dicer removes hairpin loop to produce short 22 nucleotide
dsRNA. dsRNA associates with AGO2 protein to form the RISC. mRNA strands are
unwound, one is destroyed, the other (guide) strand base pairs with complementary
sequence in specific mRNA 3'UTR resulting in silencing.
Explain how proteostasis is regulated by molecular chaperone proteins. - Answer-
Molecular chaperone proteins bind to exposed hydrophobic domains on unfolded
proteins and prevent aggregation. Assist in protein folding and intercellular transport.
Deliver damaged proteins to the ubiquitin-proteasome system (UPS). Damaged and
short-lived proteins are ubiquitinated and delivered to the proteasome for destruction.
, What are oncogenes? How are they generated? - Answer-Promote cell proliferation or
survival. Arise by point mutation, chromosomal translocation or gene amplification of
proto- oncogenes resulting in the overexpression of or overproduction of overactive
regulators of cell proliferation and survival.
Explain how the cell cycle is regulated. - Answer-Cell cycle progression is controlled by
specific cyclin dependent kinases. Abundance of specific cyclins change throughout the
cell cycle. Active CDKs phosphorylate proteins controlling cell cycle progression. CDK
activity regulated by: cyclin synthesis and degradation, CDK phosphorylation and
dephosphorylation, CDKI (p21) binding. Cancer cells lose control of cell cycle
checkpoints.
G1/S checkpoint: growth factors -> cyclin D -| Rb -| E2F -> cyclin E. DNA damage
checkpoint: p53 -> CDKI p21 -| CDK2- cyclin E.
Explain apoptosis regulation. - Answer-Cell death occurs by caspase activation and
controlled cellular destruction. Effector caspases are cleaved and activated by initiator
caspases.
BCL-2 family proteins: regulate cytochrome c release from mitochondria which leads to
apoptosome formation and caspase-9 (inhibitor) activation. Activated BAX protein (pro-
apoptotic BCL-2 family protein) forms channels in the mitochondrial outer membrane
allowing cytochrome c release. BCL-2 (anti-apoptotic BCL-2 family protein) prevents
BAX activation. Pro-apoptotic BCL-2 family members inhibit the anti-apoptotic members
and directly activate BAX.
What is Src? How is it related to cancer? - Answer-Intracellular kinase controlling cell
proliferation. V-src gene is truncated version of c-src producing a constitutively active
kinase. Conversion of human src proto-oncogene to an oncogene occurs by acquisition
of a point mutation leading to constitutively active src protein.
What is Ras? How is it related to cancer? - Answer-Monomeric G-protein (GTP bound:
active, GDP bound: inactive) which transmits signals from receptor tyrosine kinases to
intracellular kinases that control cell proliferation. Point mutation in RasD Glycine 12 to
Valine which abolishes GTPase activity resulting in constitutive activity.
Describe the genetic mutations responsible for chronic myelogenous leukemia and
Burkitt's lymphoma. - Answer-Philadelphia chromosome: reciprocal translocation
between chromosomes 9 and 22 creating fusion protein bcr-abl with constitutive
intracellular tyrosine kinase activity resulting in chronic myelogenous leukemia.
Reciprocal translocation between chromosomes 8 and 14 places c-myc gene under the
control of a strong immunoglobulin gene enhancer resulting in overproduction of c-myc
protein (regulates apoptosis and cell growth) in Burkitt's lymphoma.